Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions

Geetha, Duvuru; Kronbichler, Andreas; Rutter, Megan; Bajpai, Divya; Menez, Steven; Weißenbacher, Annemarie; Anand, Shuchi; Lin, Eugene; Carlson, Nicholas; Sozio, Stephen M.; Fowler, Kevin; Bignall, Ray; Ducharlet, Kathryn; Tannor, Elliot Koranteng; Wijewickrama, Eranga; Hafiz, Muhammad I. A.; Tesař, Vladimı́r; Hoover, Robert S.; Crews, Deidra C.; Varnell, Charles D.; Danziger‐Isakov, Lara; Jha, Vivekanand; Mohan, Sumit; Parikh, Chirag R.; Luyckx, Valérie A.

doi:10.1038/s41581-022-00618-4

Cited by 52 publications

(51 citation statements)

References 162 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The coronavirus disease 2019 (COVID-19) pandemic significantly affected individuals suffering from chronic medical conditions, such as chronic kidney disease (CKD), in terms of risk of infection, morbidity, and mortality [ 1 ]. Individuals suffering from CKD were reported to be at high risk of COVID-19 infection due to their dependence on in-center dialysis treatment, which is a high-risk environment for the transmission of COVID-19 infection [ 2 ]. Studies have also consistently shown that patients with CKD on hemodialysis carry an elevated risk of morbidity and mortality from COVID-19 [ 3 , 4 , 5 ].…”

Section: Introductionmentioning

confidence: 99%

COVID-19 Booster Vaccine Hesitancy among Hemodialysis Patients in Saudi Arabia Using the Health Belief Model: A Multi-Centre Experience

et al. 2022

View full text Add to dashboard Cite

Objective: Vaccination hesitance for the COVID-19 booster dosage among hemodialysis patients is an important barrier in reducing morbidity and mortality linked to COVID-19 infection. Hence, this study aimed to explore the predictors of the third (booster) dose of COVID-19 vaccine intention among CKD patients on hemodialysis from the Kingdom of Saudi Arabia (KSA). Methods: This study was a multi-center cross-sectional study conducted at four dialysis centers in KSA from 13 February 2022 to 21 June 2022. The data was collected by the nephrologist in charge of the unit using a structured study questionnaire, which consisted of four parts; socio-demographic and clinical variables, questions about COVID-19 infection and subjective assessment of health state, COVID-19 booster dose vaccination intention and confidence in vaccines and preferences, and a health belief model. The study population consisted of 179 hemodialysis patients. Results: Participants in the study had conflicting health beliefs about their vulnerability to COVID-19 infection and the severity of the COVID-19 infection. Study participants expressed positive health beliefs about the advantages of the COVID-19 booster dose, and reported less perceived obstacles in receiving the vaccine. The influence of cues on action among the study population was high. A total of 140 (78.2%) hemodialysis patients expressed their intention to receive the COVID-19 booster dose. Patients who reported poor health in the self-rating of their health status had a substantially higher definite intention to take the COVID-19 booster dose, according to the chi-square test (11.16, df = 3, p = 0.01). There was a significant association between the constructs in the HBM model and COVID-19 vaccine (booster) intention. Marital status (OR = 1.67, CI 1.07–2.58) was found to be the strongest predictors of a definite intention to receive a COVID-19 booster dose. Confidence in the locally manufactured vaccine (OR = 0.33, CI 0.17–0.60), education (OR = 0.62, CI 0.41–0.93), and rating of health status (OR = 0.43 CI 0.25–0.74) were the strongest significant correlates of having no definite intention to take the COVID-19 vaccination. Conclusions: HBM constructs were found to be significantly associated with vaccination intention, which can be considered while planning policies to promote COVID-19 booster vaccination among hemodialysis patients. The study results could be utilized in drafting policies to improve COVID-19 booster dose vaccination uptake among hemodialysis population.

show abstract

Section: Introductionmentioning

confidence: 99%

COVID-19 Booster Vaccine Hesitancy among Hemodialysis Patients in Saudi Arabia Using the Health Belief Model: A Multi-Centre Experience

et al. 2022

View full text Add to dashboard Cite

show abstract

“…New or modified procedures and new methodologies/technologies in care processes have been incorporated for the clinical care of patients. Possibility of access, difficulty, or limitations for the implementation of these new methodologies/technologies, and acceptance/ adaptation by professionals and patients have shown a wide variety [ 52 ].…”

Section: Discussionmentioning

confidence: 99%

Best practices during COVID-19 pandemic in solid organ transplant programs in Spain

Pascual

Mazuecos

Sánchez-Antolín

et al. 2023

Transplantation Reviews

View full text Add to dashboard Cite

“…The NIH also has a clinical trial underway to study if immune responses to vaccination improve when immunosuppression medication is temporarily reduced in the days leading up to and following vaccination (76,77). Though still unmatched to the general population, as boosters became available in the US, data shows that additional mRNA inoculations increase antibody titers for the majority of solid organ transplant patients (78,79).…”

Section: Vaccination Policies: History Present and Solutions Historymentioning

confidence: 99%

The impact of COVID-19 on kidney transplant care

Zhang

Kodali²,

Mour³

et al. 2023

Front. Med.

View full text Add to dashboard Cite

The SARS-CoV-2 virus precipitated the coronavirus 2019 (COVID-19) pandemic, which placed considerable strain on healthcare systems and necessitated immediate and rapid alterations in the delivery of healthcare. In the transplant population, COVID-19 directly impacts an inherently vulnerable population in the setting of immunosuppression and co-morbidities, but also further complicates the clinical evaluation and management of kidney transplant candidates and recipients in a strained healthcare environment being challenged by the pandemic. Many transplant centers around the world saw mortality rate spikes in organ recipients related to COVID-19, and changes in care delivery abound. This review evaluates the care of the kidney transplant patient through all phases of the process including pre-operative evaluations, perioperative care, post-transplantation considerations, and how the global pandemic has changed the way we care for our patients.

show abstract

Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions

Cited by 52 publications

References 162 publications

COVID-19 Booster Vaccine Hesitancy among Hemodialysis Patients in Saudi Arabia Using the Health Belief Model: A Multi-Centre Experience

COVID-19 Booster Vaccine Hesitancy among Hemodialysis Patients in Saudi Arabia Using the Health Belief Model: A Multi-Centre Experience

Best practices during COVID-19 pandemic in solid organ transplant programs in Spain

The impact of COVID-19 on kidney transplant care

Contact Info

Product

Resources

About